BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7329408)

  • 1. Cytokinetic and biochemical effects of sangivamycin in human colon carcinoma cells in culture.
    Glazer RI; Hartman KD
    Mol Pharmacol; 1981 Nov; 20(3):657-61. PubMed ID: 7329408
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro translational activity of messenger RNA following treatment of human colon carcinoma cells with sangivamycin.
    Glazer RI; Hartman KD
    Mol Pharmacol; 1983 Nov; 24(3):509-12. PubMed ID: 6633511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic effects of sangivamycin in sarcoma 180 in vitro.
    Ritch PS; Glazer RI; Cunningham RE; Shackney SE
    Cancer Res; 1981 May; 41(5):1784-8. PubMed ID: 7214345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the inhibitory activities of sangivamycin and thiosangivamycin on nuclear ribonucleic acid synthesis in L1210 cells in vitro.
    Glazer RI; Peale AL
    Biochem Pharmacol; 1980 Feb; 29(3):305-10. PubMed ID: 7362643
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
    Glazer RI; Lloyd LS
    Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and biochemical effects of chartreusin on mammalian cells.
    Li LH; Clark TD; Murch LL; Wooden JM; Pschigoda LM; Krueger WC
    Cancer Res; 1978 Sep; 38(9):3012-8. PubMed ID: 567097
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. II. Effects on macromolecular synthesis in cell culture and evidence for alkylating activity.
    Brockman RW; Shaddix SC; Williams M; Struck RF
    Cancer Treat Rep; 1976 Sep; 60(9):1317-24. PubMed ID: 1016967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sangivamycin and xylosyladenine on the synthesis and methylation of polysomal ribonucleic acid in Ehrlich ascites cells in vitro.
    Glazer RI; Hartman KD; Cohen OJ
    Biochem Pharmacol; 1981 Oct; 30(19):2697-701. PubMed ID: 7295353
    [No Abstract]   [Full Text] [Related]  

  • 9. Preferential incorporation of sangivamycin into ribonucleic acid in Sarcoma 180 cells in vitro.
    Ritch PS; Glazer RI
    Biochem Pharmacol; 1982 Jan; 31(2):259-61. PubMed ID: 7059368
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the cellular and RNA-dependent effects of sangivamycin and toyocamycin in human colon carcinoma cells.
    Cohen MB; Glazer RI
    Mol Pharmacol; 1985 Mar; 27(3):349-55. PubMed ID: 2579317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary screening of antitumor antibiotics inhibiting synthesis of nucleic acids in tumor cells].
    Makukho LV; Ivanitskaia LP; Volkova LIa; Preobrazhenskaia TP; Terekhova LP
    Antibiotiki; 1972 Feb; 17(2):117-21. PubMed ID: 4502567
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the rate of recovery from inhibition of RNA synthesis in mouse liver and transplantable glioma.
    Yarbro JW; Kennedy BJ
    Cancer Res; 1967 Oct; 27(10):1779-82. PubMed ID: 6064957
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective inhibition of pyrimidine biosynthesis and effect on proliferative growth of colonic cancer cells.
    Tsuboi KK; Edmunds NH; Kwong LK
    Cancer Res; 1977 Sep; 37(9):3080-7. PubMed ID: 884665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular and cellular bases of cytostatic therapy].
    Schindler R
    Schweiz Med Wochenschr; 1974 Feb; 104(8):271-4. PubMed ID: 4814678
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical aspects of chemotherapy of mouse colon carcinoma: fluoropyrimidines and pyrazofurin.
    Brockman RW; Shaddix SC; Rose LM
    Cancer; 1977 Nov; 40(5 Suppl):2681-91. PubMed ID: 144558
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytokinetic and biochemical effects of 5-iminodaunorubicin in human colon carcinoma in culture.
    Glazer RI; Hartman KD; Richardson CL
    Cancer Res; 1982 Jan; 42(1):117-21. PubMed ID: 7053840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.
    Cohen MB; Glazer RI
    Mol Pharmacol; 1985 Feb; 27(2):308-13. PubMed ID: 2578606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 8-azaadenosine and formycin on cell lethality and the synthesis and methylation of nucleic acids in human colon carcinoma cells in culture.
    Glazer RI; Lloyd LS
    Biochem Pharmacol; 1982 Oct; 31(20):3207-14. PubMed ID: 7150349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimation of tumor sensitivity in vitro. II. Studies with the solid Ehrlich carcinoma of the mouse and the GW 77, a heterotransplanted human carcinoma].
    Seidel HJ
    Z Krebsforsch; 1970; 74(2):131-40. PubMed ID: 4103128
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells.
    Ohno O; Shima Y; Ikeda Y; Kondo SI; Kato K; Toi M; Umezawa K
    Int J Oncol; 2001 May; 18(5):1009-15. PubMed ID: 11295049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.